Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.
Infectious Disease
Safety, Tolerability, Immunogenicity of the Novel Pneumococcal Conjugate Vaccine V114 in Patients at Risk for Pneumococcal Disease
Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.
Sequential Mechanical Ventilation Effective in Treating Tuberculosis With Respiratory Failure
The researchers assessed the efficacy and safety of sequential mechanical ventilation in the treatment of tuberculosis with respiratory failure.
Oral-Only Dosing Regimen of Omadacycline Approved for CABP
Previously, the initial loading dose of Nuzyra for CABP was administered only by IV infusion.
FDA: Current Data Do Not Support Leronlimab for COVID-19
Results showed both trials of leronlimab did not meet primary or secondary endpoints.
Invasive Aspergillosis Superinfection Possible in Symptomatic COVID-19
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
Influenza Vaccine for Older Adults Granted Fast Track Status
The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years.
Oseltamivir Reduces Recovery Time for Influenza-Like Illness in European Study
Oseltamivir may reduce recovery time for primary care patients with influenza-like illness, especially for older, sicker patients with comorbidities.
- Loading...
Loading...
Next post in Influenza
Loading... 
Loading...